Gonadotropins & Cox-2 in Ovarian Cancer Prevention
促性腺激素
基本信息
- 批准号:6588263
- 负责人:
- 金额:$ 40.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-05-01 至 2008-04-30
- 项目状态:已结题
- 来源:
- 关键词:basement membrane cancer prevention chemoprevention collagen collagenase fatty acid biosynthesis gene mutation gene targeting genetically modified animals gonadotropins indomethacin laboratory mouse laminin neoplastic transformation nonsteroidal antiinflammatory agent ovary neoplasms oxidoreductase inhibitor prostaglandin endoperoxide synthase prostaglandins tissue /cell culture
项目摘要
DESCRIPTION (provided by applicant): The gonadotropin stimulation hypothesis is a leading idea in the etiology of ovarian cancer explaining the association of cancer risk with the number of ovulatory cycles. However, gonadotropins have only unremarkable effects on the growth of ovarian surface epithelial cells in culture. Thus, a convincing mechanism for the ovarian carcinogenic activity of gonadotropins is lacking. Recently, we found that pre-neoplastic ovarian surface epithelia that are located immediately adjacent to morphologically neoplastic lesions often lack basement membranes and have proposed that the loss of basement membrane is an early step in ovarian tumorigenicity. Thus, we hypothesize a mechanism for the carcinogenic effect of gonadotropins, that the hormones stimulate the loss of basement membranes similar to pre-ovulatory events. As a result, the frequent placement of the ovarian surface epithelium in such a basement membrane-less, pre-neoplastic stage by repeated gonadotropin stimulation increases the frequency for tumor prone cells to transform Gonadotropins induce Cox-2 in both granulosa and surface epithelial cells to mediate ovulation, and the loss of basement membrane and other ovulatory events can be blocked by inhibition of the Cox enzymes. The W or Wv mice are predisposed to tubular adenoma formation from the ovarian surface epithelium. The cause of ovarian neoplasm is thought to be the elevated serum gonadotropins in these spontaneously mutant mice. Another genetically engineered mutant mouse, the Disabled-2 (Dab2) heterozygous knockout model, is also predisposed to the development of ovarian surface epithelial dysplasia and papillomatosis, the pre-malignant lesions of ovarian cancer. We speculate that the combination of Wv/Wv and Dab2 () genotypes will augment the predisposition to ovarian neoplasm. We will test if the inhibition of Cox enzymes reduces the gonadotropin stimulated basement membrane loss, and inhibits or reduces the predisposition of the Wv/Wv, Dab2 () mice to develop ovarian tumors. To investigate the mechanisms, we will also examine the effects of gonadotropin stimulation on the expression of Cox-2, collagen IV, laminin, and MMPs in ovarian surface epithelial cells in culture. These studies will help to understand the etiology of ovarian cancer related to gonadotropins, and provide a mechanism(s) for the chemopreventive activity of Cox-2 inhibitors.
描述(由申请人提供):促性腺激素刺激假说是卵巢癌病因学的主要观点,解释了癌症风险与排卵周期数的相关性。 然而,促性腺激素对培养的卵巢表面上皮细胞的生长只有不显著的影响。 因此,促性腺激素的卵巢致癌活性缺乏一个令人信服的机制。 最近,我们发现肿瘤前的卵巢表面上皮细胞位于形态学上肿瘤性病变附近,通常缺乏基底膜,并提出基底膜的丧失是卵巢致瘤性的早期步骤。 因此,我们假设促性腺激素的致癌作用机制,即激素刺激类似于排卵前事件的基底膜损失。 结果,通过反复促性腺激素刺激,卵巢表面上皮细胞频繁地置于这种无基底膜的肿瘤前阶段,增加了肿瘤倾向细胞转化促性腺激素的频率,在颗粒细胞和表面上皮细胞中诱导考克斯-2介导排卵,并且基底膜的丧失和其他排卵事件可以通过抑制考克斯酶来阻断。W或Wv小鼠倾向于从卵巢表面上皮形成管状腺瘤。 卵巢肿瘤的原因被认为是这些自发突变小鼠血清促性腺激素升高。 另一种基因工程突变小鼠,残疾人-2(Dab 2)杂合敲除模型,也倾向于发展卵巢表面上皮异型增生和乳头状瘤病,卵巢癌的癌前病变。 我们推测,Wv/Wv和Dab 2()基因型的组合将增加卵巢肿瘤的易感性。 我们将测试考克斯酶的抑制是否减少促性腺激素刺激的基底膜损失,并抑制或减少Wv/Wv,Dab 2()小鼠发展卵巢肿瘤的倾向。 为了研究其机制,我们还将检测促性腺激素刺激对培养的卵巢表面上皮细胞中考克斯-2、IV型胶原、层粘连蛋白和MMPs表达的影响。 这些研究将有助于了解促性腺激素相关的卵巢癌病因,并为考克斯-2抑制剂的化学预防活性提供机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
XiangXi Mike Xu其他文献
XiangXi Mike Xu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('XiangXi Mike Xu', 18)}}的其他基金
Ovarian Epithelial Cancer Progenitor Cell Population
卵巢上皮癌祖细胞群
- 批准号:
10524246 - 财政年份:2018
- 资助金额:
$ 40.6万 - 项目类别:
Ovarian Epithelial Cancer Progenitor Cell Population
卵巢上皮癌祖细胞群
- 批准号:
10060282 - 财政年份:2018
- 资助金额:
$ 40.6万 - 项目类别:
Ovarian Epithelial Cancer Progenitor Cell Population
卵巢上皮癌祖细胞群
- 批准号:
9918266 - 财政年份:2018
- 资助金额:
$ 40.6万 - 项目类别:
Ovarian Epithelial Cancer Progenitor Cell Population
卵巢上皮癌祖细胞群
- 批准号:
10391479 - 财政年份:2018
- 资助金额:
$ 40.6万 - 项目类别:
Mechanism of Cox-2 Inhibition in Ovarian Cancer Prevention
抑制 Cox-2 预防卵巢癌的机制
- 批准号:
6958678 - 财政年份:2004
- 资助金额:
$ 40.6万 - 项目类别:
相似海外基金
Development of an HPV stigma assessment scale and a stigma-reducing intervention to improve cervical cancer prevention in El Salvador
制定 HPV 耻辱评估量表和减少耻辱干预措施,以改善萨尔瓦多的宫颈癌预防
- 批准号:
10844859 - 财政年份:2023
- 资助金额:
$ 40.6万 - 项目类别:
Advancing skin cancer prevention by tackling UV-induced clonogenic mutations
通过应对紫外线诱导的克隆突变来促进皮肤癌的预防
- 批准号:
10829054 - 财政年份:2023
- 资助金额:
$ 40.6万 - 项目类别:
KEMRI-PHRD UG1 CASCADE NETWORK UNIT: CERVICAL CANCER PREVENTION FOR WOMEN LIVING WITH HIV RESEARCH
KEMRI-PHRD UG1 级联网络单元:艾滋病毒感染女性的宫颈癌预防研究
- 批准号:
10763054 - 财政年份:2023
- 资助金额:
$ 40.6万 - 项目类别:
Implementing HIV/Cervical Cancer Prevention CASCADE Clinical Trials in Zimbabwe (ZIM-CASCADE)
在津巴布韦实施艾滋病毒/宫颈癌预防 CASCADE 临床试验 (ZIM-CASCADE)
- 批准号:
10758129 - 财政年份:2023
- 资助金额:
$ 40.6万 - 项目类别:
TOPIC 453: THE PERFECT MEDICAL ASSISTANT FOR CANCER PREVENTION WITHIN PRIMARY CARE
主题 453:初级保健中预防癌症的完美医疗助手
- 批准号:
10931123 - 财政年份:2023
- 资助金额:
$ 40.6万 - 项目类别:
Co-creating a community engagement knowledge translation summit on improving cancer prevention and screening in Canada
共同创建社区参与知识翻译峰会,以改善加拿大的癌症预防和筛查
- 批准号:
480839 - 财政年份:2023
- 资助金额:
$ 40.6万 - 项目类别:
Miscellaneous Programs
PIECES – Towards Large-Scale Adaption and Tailored Implementation of Evidence-Based Primary Cancer Prevention Programmes in Europe and Beyond
部分内容 — 致力于在欧洲及其他地区大规模适应和定制实施循证初级癌症预防计划
- 批准号:
10079747 - 财政年份:2023
- 资助金额:
$ 40.6万 - 项目类别:
EU-Funded
Bacteria-derived xenobiotics in colon cancer prevention: Link to GPR109A and colonic ketogenesis
细菌源性异生素在结肠癌预防中的作用:与 GPR109A 和结肠生酮的联系
- 批准号:
10737017 - 财政年份:2023
- 资助金额:
$ 40.6万 - 项目类别:
A Hybrid Implementation-Effectiveness Trial of Game Changers for Cervical Cancer Prevention in Uganda
乌干达宫颈癌预防游戏规则改变者的混合实施-有效性试验
- 批准号:
10718609 - 财政年份:2023
- 资助金额:
$ 40.6万 - 项目类别:
Using mHealth to investigate intersectionality and health behaviors: Implications for conceptual models and cancer prevention interventions for marginalized populations
使用移动医疗研究交叉性和健康行为:对边缘化人群的概念模型和癌症预防干预措施的影响
- 批准号:
10746886 - 财政年份:2023
- 资助金额:
$ 40.6万 - 项目类别:














{{item.name}}会员




